Nolvadex

This page contains recent news articles, when available, and an overview of Nolvadex but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.


Overview:

Nolvadex
(when available)

Pharmacology and use:
Tamoxifen belongs to a class of drugs called selective estrogen receptor modulators (SERMs), which have both estrogenic and antiestrogenic effects. Tamoxifen has the same nucleus as diethylstilbestrol but possesses an additional side chain (trans isomer) which accounts for its antiestrogenic activity. Tamoxifen, chemically related to clomiphene., is used to in the therapy of metastatic breast cancer. for the treatment of breast cancer

Mechanism Of Action:
Tamoxifen binds to estrogen receptors (ER), inducing a conformational change in the receptor. This results in a blockage or change in the expression of estrogen dependent genes. The prolonged binding of tamoxifen to the nuclear chromatin of these results in reduced DNA polymerase activity, impaired thymidine utilization, blockade of estradiol uptake, and decreased estrogen response. It is likely that tamoxifen interacts with other coactivators or corepressors in the tissue and binds with different estrogen receptors, ER-alpha or ER-beta, producing both estrogenic and antiestrogenic effects.

News Articles on Tamoxifen

Women at High Risk for Breast Cancer Do Not Take Tamoxifen for Prevention  -  ‎Dec 22, 2009‎
...reported that women at high-risk of breast cancer understand the risks and benefits of tamoxifen [Nolvadex®] prevention, but only 6% choose to take it. ... Cancer Consultants

Non-adherence Rate for Adjuvant Hormonal Therapy for Breast Cancer is 40%  -  ‎Dec 29, 2009‎
Researchers from the British Columbia Cancer Agency have reported that the non-adherence rate for tamoxifen (Nolvadex®) and aromatase inhibitors (AIs) in ... Cancer Consultants

High Soy Protein Consumption May Lower Risk of Breast Cancer Recurrence  -  ‎Dec 11, 2009‎
This effect was also seen in women taking tamoxifen [Nolvadex®] and in women not taking tamoxifen. Comments: These data clearly show that a high intake of ... Cancer Consultants

Anti-estrogens May Reduce Risk of Lung Cancer Death  -  ‎Dec 15, 2009‎
Researchers from Switzerland have reported that anti-estrogens (such as tamoxifen [Nolvadex®]) used as treatment for breast cancer may also reduce the risk ... Cancer Consultants

Oncotype DX® Influences Treatment Decisions in Node-positive Breast Cancer  -  ‎Dec 16, 2009‎
...breast cancer but a low Recurrence Score did not appear to benefit from the addition of chemotherapy to hormonal therapy with tamoxifen [Nolvadex®]. ... Cancer Consultants

Higher Dose of Faslodex® May Delay Breast Cancer Progression  -  ‎Dec 15, 2009‎
Among postmenopausal, hormone-positive breast cancer patients, Faslodex reduces recurrences when used following two years of tamoxifen [Nolvadex®] compared ... Cancer Consultants

Generic Name: Tamoxifen, Istubal, Valodex, Soltamox, Genox, Tamofen  -  ‎Nov 11, 2009‎
Nolvadex works by blocking the effects of a female hormone oestrogen (estrogen) which is required by certain types of breast cancer to grow. ... Pattaya Daily News

FYI: 10 Things That Increase Cancer Risk  -  ‎Nov 2, 2009‎
For example, tamoxifen (Nolvadex) is a medication used to treat breast cancer; however, potential side effects of the drug include the development of ... Greenwood Today

Aromasin nel trattamento del tumore al seno a insorgenza precoce  -  ‎Nov 4, 2009‎
Il trattamento adiuvante nelle donne con tumore mammario precoce endocrino-sensibile è stato dominato negli ultimi 40 anni dal Tamoxifene ( Nolvadex ). ... XagenaSalute

Purchase Nolvadex COD  -  Apr 8, 2007
...safety and Purchase Nolvadex COD of prescription drugs in the US is regulated by the European Union, the main body that regulates pharmaceuticals is the ... Sokwanele

AIDS Drugs May Help Against Cancer, Too  -  Sep 18, 2007
Nelfinavir was also found to be effective against breast cancer cells that are resistant to currently used cancer drugs like Nolvadex (tamoxifen) and ... New York Times

Generic Nolvadex  -  Oct 8, 2007
...demand for their potential new product before spending an outlay of company funds.[2] * Obtain a patent on the legal jurisdiction. ... Sokwanele

Tamoxifen (Nolvadex): Is it REALLY Working for You?  -  Feb 26, 2008
Thanks to fellow SharePoster Jolene Boyd, a startling issue involving tamoxifen was recently brought to light. Jolene's recent post on this site cited some ... HealthCentral.com

ARIMIDEX(R) (anastrozole) Featured in Studies Evaluating Impact of …  -  Dec 9, 2005
In some NOLVADEX adjuvant studies, most of the benefit to date has been in the ... WARNING: Serious and life-threatening events associated with NOLVADEX ... Free with registration - PR Newswire - AccessMyLibrary.com

AstraZeneca to halt sales of breast cancer drug Nolvadex  -  Apr 14, 2006
AstraZeneca will stop selling its breast cancer drug Nolvadex (tamoxifen) by the end of June, according to a letter posted on the FDA's Web site this week. ... PR Week - PRWeek

Aromatase Inhibitors Declared Superior to Tamoxifen in the Adjuvant …  -  Aug 1, 2006
In some Nolvadex adjuvant studies, most of the benefit to date has been in the ... WARNING: Serious and life-threatening events associated with Nolvadex ... DG News

Buy Nolvadex COD  -  Aug 12, 2007
...and Behavior study of chemicals requires intimate knowledge of the Buy Nolvadex COD Buy Nolvadex COD dosage of any drug approved for use is intended to fall ... Sokwanele

DR. PAUL DONOHUE GOOD HEALTH  -  Jul 3, 2005
One adjuvant drug, Nolvadex (tamoxifen), prevents estrogen from attaching to cancer cells. A new class of adjuvant drugs, which includes Femara, ... Pay-Per-View - South Florida Sun - Sentinel - ProQuest Archiver

Aromatase Inhibitors Declared Superior To Tamoxifen In The Adjuvant …  -  Aug 3, 2006
In some NOLVADEX adjuvant studies, most of the benefit to date has been in the ... WARNING: Serious and life-threatening events associated with NOLVADEX ... Medical News Today - Medical News Today (press release)

No Side Effects from Tamoxifen (Nolvadex)? Why It May Not Be Working  -  Feb 15, 2008
Research on the possibility of a drug interaction between tamoxifen (nolvadex) and serotonin reuptake inhibitors (SSRIs) - a class of drugs that includes ... HealthCentral.com

FDA Safety Labeling Changes: Vistaril, Estraderm, Nolvadex  -  Mar 2, 2005
March 2, 2005 — The US Food and Drug Administration (FDA) approved in December 2004 revisions to safety labeling to advise healthcare professionals of the ... Medscape

Tamoxifen (Nolvadex) and Fareston FAQs: Hormone Therapies to …  -  Apr 4, 2008
Q. I was diagnosed with ER-receptive breast cancer and have had a lumpectomy and radiation. Now my oncologist has prescribed tamoxifen. ... HealthCentral.com

Oncotype DXâ„¢ Accurately Measures Estrogen Receptor Status in Node- …  -  Dec 14, 2006
This trial included 297 node-negative, ER-positive breast cancer patients who had already received treatment with Nolvadex® (tamoxifen) in the prior NSABP ... Cancer Consultants

Tamoxifen (Nolvadex) and Arimidex: In the News Again  -  Apr 6, 2007
The blogwaves were buzzing recently with the news that tamoxifen (nolvadex), the once (and perhaps future) king of breast cancer prevention drugs, ... HealthCentral.com

Few women willing to use AstraZeneca's Nolvadex, study shows  -  Apr 11, 2005
Fewer than one in five women eligible to take tamoxifen, the controversial cancer drug marketed by AstraZeneca as Nolvadex, were inclined to take the drug ... Pay-Per-View - Datamonitor News and Comment - Factiva, from Dow Jones

CYP2D6 and Tamoxifen/Nolvadex Effectiveness  -  Nov 29, 2006
Over my morning coffee and one of the three daily newspapers I read I see a note “Panel seeks Cancer-Drug Warning� hot off the AP wire. ... HealthCentral.com

Forgetting to Take Tamoxifen (Nolvadex)?  -  Feb 16, 2007
A recent study of breast cancer patients showed that about a third of women stopped taking their tamoxifen (nolvadex) before the end of the recommended 5 ... HealthCentral.com

Hormone replacement therapy has its risks  -  Jun 27, 2008
Lobular breast cancer can be treated with hormone-based therapies, such as tamoxifen (Nolvadex), if caught early. Experts believe the incidence of lobular ... News 8 Austin

High court urged not to hear reverse-pay case.(CHAIN PHARMACY)  -  Jun 25, 2007
...its own generic version of Astra's tamoxifen breast cancer medication, marketed under the brand name Nolvadex, until the patent on Nolvadex had expired. ... Free with registration - Drug Store News - AccessMyLibrary.com

Breast Cancer Drug Reduces Risk of Heart Disease  -  Feb 15, 2005
...(Ivanhoe Newswire) -- Researchers have discovered women treated with the anti-estrogen drug tamoxifen (Nolvadex) are less likely to have a heart attack or ... Ivanhoe Broadcast News

ATAC trialists back up-front use of anastrozole.(Women's Health)(Alone...  -  Sep 1, 2006
The ATAC trial and many of the investigators, including Dr. Buzdar, received financial support from AstraZeneca, maker of anastrozole and of Nolvadex, ... Free with registration - Family Practice News - AccessMyLibrary.com

… .(Branded Drugs)(AstraZeneca PLC to stop Nolvadex sales)(Brief...  -  May 1, 2006
...to cease.(Branded Drugs)(AstraZeneca PLC to stop Nolvadex sales)(Brief article) ... find Chain Drug Review articles. AstraZeneca PLC will stop selling ... Pay-Per-View - Chain Drug Review - HighBeam Research

Supreme Court Will Not Hear Tamoxifen Case  -  Jun 27, 2007
...review an appeals court ruling in a reverse-payment case involving Barr Laboratories agreeing not to market a generic version of AstraZeneca's Nolvadex. ... FDA news - FDA news (subscription)

FDA Grants Fast Review For Novartis Cancer Drug  -  Aug 31, 2005
...an advantage over tamoxifen in trials. AstraZeneca's rival product is Arimidex. Tamoxifen is made by AstraZeneca under the brand name of Nolvadex. Subscription - Wall Street Journal Online - Dow Jones & Company

AstraZeneca Plans to Stop Selling Breast-Cancer Drug  -  Apr 11, 2006
The FDA first approved Nolvadex in 1977 by then-manufacturer Zeneca Pharmaceuticals, which later merged with Astra to form UK-based AstraZeneca. ... Subscription - Wall Street Journal Online - Dow Jones & Company

Prophylactic mastectomy: Breast cancer prevention for high-risk women  -  Nov 30, 2007
Tamoxifen (Nolvadex), the first drug used for this purpose, has long been prescribed to prevent breast-cancer recurrence in women who have already been ... MayoClinic.com

ARIMIDEX(R) Gains Full FDA Approval for Adjuvant Treatment of …  -  Sep 21, 2005
In some NOLVADEX adjuvant studies, most of the benefit to date has been ... For most women with breast cancer, the benefits of NOLVADEX outweigh its risks. ... Medical News Today - Medical News Today (press release)

AstraZeneca buys UK cancer research firm  -  Jan 4, 2006
AstraZeneca made its name in cancer, discovering the breakthrough breast cancer drug tamoxifen and launched it as Nolvadex in 1973. ... Pharmafocus

Method to Restore Tamoxifen Sensitivity in Resistant Breast Cancer  -  Dec 20, 2006
The widely used breast cancer drug tamoxifen (Nolvadex ), which can become less effective over time, might retain its full strength indefinitely if used ... emaxhealth.com

Learn about Exemestane from Consumer Reports Health.  -  Jan 3, 2007
...end of monthly menstrual periods) and who have already been treated with a medication called tamoxifen (Nolvadex) for 2-3 years. ... consumerreports.org

New oestrogen receptor opens up drug possibilities  -  Jun 12, 2006
Tamoxifen was invented by AstraZeneca and is sold under the brand names Nolvadex, Istubal, and Valodex. It is also available as a generic drug in a number ... DrugResearcher.com

Osteoporosis after Breast Cancer  -  Jun 22, 2007
Another commonly prescribed chemotherapy agent, tamoxifen (Nolvadex), is actually a selective estrogen receptor modulator related to a drug used to ... HealthCentral.com

Clonidine and Gabapentin Effective for Hot Flashes  -  Sep 1, 2006
The effectiveness of clonidine is strongest in women taking tamoxifen (Nolvadex) for breast cancer. Two fair-quality trials of gabapentin (Neurontin) ... AAFP News Now

5 Years Of Treatment With Arimidex(R) Didn't Cause Osteoporosis In …  -  Jun 5, 2006
In some NOLVADEX adjuvant studies, most of the benefit to date has been in the ... WARNING: Serious and life-threatening events associated with NOLVADEX ... Medical News Today - Medical News Today (press release)

Dos años de sanción a Raúl Fernández por dopaje  -  Mar 12, 2005
El atleta dice que tomó «nolvadex», un medicamento que le prescribió un médico y que se puede adquirir en cualquier farmacia, para curarse después de cinco ... ABC.es

Cancer du sein: l'Evista aussi efficace que le Nolvadex, moins d'effet...  -  Apr 17, 2006
WASHINGTON (AFP) - Le médicament Evista du laboratoire américain Eli Lilly est aussi efficace que le Nolvadex d'AstraZeneca pour réduire les risques de ... Atlasvista Maroc

Loislaw Federal District Court Opinions - SCHMIDT v. FORTIS …  -  Jan 3, 2005
September 22, 1992 — "Her routine medication is Nolvadex. ... She has questions concerning continuing Nolvadex, effects of lack of Estrogen on heart attack, ... Pay-Per-View - Loislaw Federal District Court Opinions - Loislaw

Survival from breast cancer in England and Wales up to 2001  -  Sep 23, 2008
In 1985, the Nolvadex Adjuvant Trial Organisation study was the first randomised trial to show an overall survival advantage in patients receiving adjuvant ... Nature.com

Article: United States Court of Appeals denies rehearing request in …  -  Sep 1, 2006
Article: FDA Advisory Panel Recommends Approval of Zeneca's Nolvadex ... ... Roche Laboratories to co-promote NOLVADEX(R) in the United States. ... Pay-Per-View - BIOTECH Patent News - HighBeam Research

Loislaw Federal District Court Opinions - SCHMIDT v. FORTIS INS. CO....  -  Jan 3, 2005
September 22, 1992 — "Her routine medication is Nolvadex. ... She has questions concerning continuing Nolvadex, effects of lack of Estrogen on heart attack, ... Pay-Per-View - Loislaw Federal District Court Opinions - Loislaw

Studio ATAC a 100 mesi: i vantaggi di Anastrozolo rispetto al...  -  Dec 17, 2007
Tamoxifen, Alone or in Combination ) hanno confermato che Anastrozolo ( Arimidex ) è significativamente più efficace del Tamoxifene ( Nolvadex ) nella ... XagenaSalute

Press Release: US Court of Appeals Denies Rehearing Request in …  -  Sep 18, 2006
Article: FDA Advisory Panel Recommends Approval of Zeneca's NOLVADEX(R) ... ... Article: Barr Receives Approval for Generic Nolvadex(R) 10 mg and 20 mg ... ... Pay-Per-View - PR Newswire - HighBeam Research

Anastrazole May Be More Effective Than Tamoxifen for Early Breast …  -  Aug 11, 2008
Treatment regimens were similar for the Italian Tamoxifen Anastrazole, Austrian Breast and Colorectal Cancer Study Group, and Arimidex-Nolvadex trials. ... Medscape

AstraZeneca: Drar in Nolvadex i slutet av juni - Tidning  -  Apr 12, 2006
Läkemedelsföretaget AstraZeneca drar in sin försäljning av läkemedlet tamoxifen, marknadsfört under namnet Nolvadex, i slutet av juni på grund av sjunkande ... Affärsvärlden - Affärsvärlden

Potenziali applicazioni degli agonisti LHRH nel carcinoma mammario …  -  Jun 18, 2007
L'aggiunta degli agonisti LHRH al Tamoxifene ( Nolvadex ), alla chemioterapia, o ad entrambi, ha ridotto le recidive tumorali del 12.7% ( p = 0.02 ) e la ... XagenaSalute

Evista Shines in Breast Cancer Trial  -  Apr 17, 2006
Tamoxifen is also sold by AstraZeneca (AZN Quote) under the brand name Nolvadex. AstraZeneca recently said it would stop selling Nolvadex in the US in June ... TheStreet.com - TheStreet.com (subscription)

Article: 32. Additional therapy with mistletoe extracts in breast...  -  Oct 1, 2007
Nolvadex, is prescribed as additional therapy after breast cancer surgery for ... Nolvadex, is prescribed as additional therapy after breast cancer surgery ... Pay-Per-View - Phytomedicine: International Journal of... - HighBeam Research

Press Release: Pooled-Analysis of 54 Clinical Studies Shows No …  -  Aug 6, 2008
Article: FDA Advisory Panel Recommends Approval of Zeneca's NOLVADEX(R) ... NOLVADEX versus placebo in women at increased risk of developing breast cancer. ... Pay-Per-View - PR Newswire - HighBeam Research

Press Release: US Supreme Court Denies Review of Tamoxifen Citrate …  -  Jun 25, 2007
Tamoxifen Citrate is the generic version of AstraZeneca's Nolvadex(R), which is indicated for the ... See all results Or, try our Advanced Search ... Pay-Per-View - PR Newswire - HighBeam Research

Reports: MLB Officials, Albany DA Met  -  Sep 11, 2007
On their own, Clomid and Nolvadex are not considered performance-enhancing drugs. A pharmacy based in Orlando, Fla., has been at the center of an ... San Francisco Chronicle

Turntables - Reviews - PC World  -  Oct 13, 2006
...<strong>BEST PRICE NOLVADEX</strong> <strong>Url: <a href="http://medstrade.com/nolvadex">http://medstrade.com/nolvadex</a></strong> . ... PC World Magazine

Generalists Equal Specialists in Follow-Up Care for Early Breast...  -  Feb 20, 2006
..."Are there data on the diffusion of new knowledge, such as adding letrozole [Femara] after five years of primary treatment with tamoxifen [Nolvadex], ... MedPage Today

GÃ¥ til nettsiden  -  Mar 25, 2008
Om du vil kan du som kvinne ta Clomid eller Nolvadex i to uker under eggløsningen, og typen din kan bruke Provironium for å forbedre sædkvaliteten. ... NRK - NRK

STRUGGLING WHITE SOX GIVE GUILLEN NEW CONTRACT -  -  Sep 12, 2007
Clomid usually is used as a female fertility medication and Nolvadex is a breast cancer treatment. The players' association confirmed the possibility of ... $2.95 - Lexington Herald Leader - NewsBank

Breast-Cancer Therapy May Benefit From Gene Testing  -  Oct 18, 2006
AstraZeneca stopped making and selling Nolvadex tablets in June because demand had dwindled as more generic versions of the drug entered the market, ... Bloomberg

'Zoladex(R)' (Goserelin) Adjuvant to Radiotherapy Found to Extend...  -  Apr 4, 2005
...'Zoladex', 'Arimidex', 'Casodex', 'Faslodex', 'Nolvadex' and 'Iressa' are trademarks of the AstraZeneca group of companies. [1] Pilepich MV, Winter K, ... RedOrbit

AROUND THE LEAGUE  -  Sep 12, 2007
Clomid usually is used as a female fertility medication and Nolvadex is a breast cancer treatment. COMMEMORATING 9/11- The New York Mets and Atlanta Braves ... $2.95 - St. Louis Post-Dispatch - NewsBank

Competitors by Product Report  -  May 10, 2008
AstraZeneca plc (ADR) (AZN) Products:. Nolvadex (Tamoxifen Citrate) ... AstraZeneca plc (ADR) (AZN) Products:. Nolvadex (Tamoxifen Citrate) ... $75.00 - Revere Reports - Revere

New treatments prevent recurrence of breast cancer for many women  -  Mar 15, 2006
After the surgery, I got radiation treatments, and I took Nolvadex. What are the chances it will come back ... You had two of them - radiation and Nolvadex. ... $3.50 - The Gazette - NewsBank

Post subject: Stopping Gyno  -  Oct 11, 2005
I've seen some mentioning of tamoxifen (nolvadex) here, ... Tamoxifen (nolvadex) without a doubt, WILL completely stop estrogen based gyno in it's tracks. ... Hairloss Talk Newsletter

Article: Breast cancer drug gets FDA nod for wider use. - San Jose …  -  Nov 17, 2006
Administration (FDA) has approved its breast cancer drug NOLVADEX ... the ... NOLVADEX(R). The FDA actions are based ... 1998 from the Breast Cancer ... Pay-Per-View - San Jose Mercury News - HighBeam Research

New International Treatment Guidelines Verify Crucial Role of 'Arimide...  -  Jul 9, 2005
...'ARIMIDEX', 'CASODEX', 'FASLODEX', 'NOLVADEX', 'ZOLADEX', 'TOMUDEX', and 'IRESSA' are trademarks, the property of the AstraZeneca group of companies. presseportal.de

Femara cuts cancer recurrence even if started late  -  Mar 10, 2008
But benefits of the pill, sold by AstraZeneca under the brand Nolvadex and also sold generically, fall significantly after five years. ... Reuters

New cancer drugs reduce recurrence  -  Mar 6, 2006
After the surgery, I got radiation treatments, and I took Nolvadex. What are the chances that it will ... You had two of them -- radiation and Nolvadex. ... Pay-Per-View - Contra Costa Times - Factiva, from Dow Jones

Arimidex.(Treatment of breast cancer )(Drug overview)  -  Dec 1, 2005
Certain drugs may decrease the effectiveness of Arimidex, including tamoxifen (Nolvadex) and estrogen-containing drugs. Be sure to tell your doctor about ... Free with registration - PDR Family Guide to Prescription Drugs - AccessMyLibrary.com

Mid-Treatment Breast Cancer Switch to Aromatase Inhibitor Boosts …  -  Nov 17, 2006
They analyzed the Austrian Breast and Colorectal Cancer Study Group (ABCSG), Arimidex-Nolvadex (ARNO 95), and the Italian Tamoxifen Anastrozole (ITA) ... MedPage Today

… reduced the risk of breast cancer recurrence by 17% over Nolvadex.(...  -  Feb 1, 2005
AstraZeneca's (Wilmington, DE) Arimidex reduced the risk of breast cancer recurrence by 17% over Nolvadex (tamoxifen) after five years of treatment, ... Free with registration - Applied Clinical Trials - AccessMyLibrary.com

Three-Million Women in the US Are Living With Breast Cancer  -  Apr 13, 2007
Faslodex increased (+39%) to $140 million whereas Nolvadex decreased (-16%) to $114 million. Novartis reported that Femara increased it sell value by +30% ... webwire.com

Eli Lilly responds to results of STAR trial comparing Evista with...  -  Apr 24, 2006
AstraZeneca recently said that it would stop selling Nolvadex in the USA in June of this year due to the dramatic impact that newly-available generic ... $4.95 - Pharma Marketletter - ECNext

Overall, Approximately 3 Million Women in The US Are Living with...  -  Apr 12, 2007
Faslodex increased (+39%) to $140 million whereas Nolvadex decreased (-16%) to $114 million. Novartis reported that Femara increased it sell value by +30% ... Genetic Engineering News - Genetic Engineering News (press release)

Will mergers and acquisitions heat up in 2008?(Mylan Laboratories...  -  Aug 6, 2007
Zeneca had paid Barr $21 million to settle its challenge to the patent for Nolvadex and gave Barr the right to sell tamoxifen made by AstraZeneca. ... Free with registration - Drug Topics - AccessMyLibrary.com

Harvard Pilgrim Health Care:  -  Mar 3, 2007
Women who also may be at high risk of endometrial cancer include women with high blood pressure and diabetes, and women who take tamoxifen (Nolvadex) for ... Intelihealth.com

Phosphagenics initiates anti-cancer compound animal trials  -  Jan 24, 2006
The gold-standard hormonal treatment for breast cancer, Nolvadex, achieved global sales of over $1bn in 2001, and Arimidex (anastrozole) sales of $0.8 ... In-PharmaTechnologist.com

Supreme Court ends challenge to reverse-payment agreements.(CHAIN …  -  Jul 23, 2007
...generic version of AstraZeneca's tamoxifen breast cancer medication, marketed under the brand name Nolvadex, until the patent on Nolvadex had expired. ... Free with registration - Drug Store News - AccessMyLibrary.com

Sujet: traitement cancer du sein  -  Jan 18, 2008
J ai pris 14ans du Nolvadex que je supportais super bien mais qui donne le cancer de l utérus, comme on me l avait ratatiné avec des rayons aussi pour ... E-Santé.fr

Vær forsiktig med Ã¥ dele opp tabletter  -  Oct 26, 2006
Blant piller som ikke bør deles opp, er blant annet brystkreftmedisinen Nolvadex, som inneholder virkestoffet tamoksifen. Å knuse ei Nolvadex-pille kan føre ... Dagbladet.no

'Zoladex(R)' (Goserelin) Adjuvant to Radiotherapy Found to Extend...  -  Apr 3, 2005
...'Zoladex', 'Arimidex', 'Casodex', 'Faslodex', 'Nolvadex' and 'Iressa' are trademarks of the AstraZeneca group of companies. [1] Pilepich MV, Winter K, ... $4.95 - PR Newswire - ECNext

ARIMIDEX HELPS WOMEN AVOID SIDE EFFECTS OF HORMONAL …  -  Nov 2, 2005
...'ARIMIDEX', 'CASODEX', 'FASLODEX', 'NOLVADEX', 'ZOLADEX', 'TOMUDEX', and 'IRESSA' are trademarks, the property of the AstraZeneca group of companies. ... $4.95 - AsiaPulse News - ECNext

Resistance to Common Breast Cancer Drug Connected to Protein  -  Nov 12, 2008
Tamoxifen is the generic name for AstraZeneca Plc's Nolvadex, no longer made in the US, which was developed 30 years ago. About 28000 US women receive ... Bloomberg

Article: Bone marrow micrometastases predict Ca risk.(Gynecology) -...  -  Mar 15, 2006
DTC advertising has been extended ... greatly increased support behind breast cancer drug Nolvadex. There no longer ... type of drugs will generate DTC ... Pay-Per-View - OB GYN News - HighBeam Research

Article: Fed: New national cancer agency to be established - AAP...  -  Nov 28, 2005
NOLVADEX(R). The data were published in the Journal of the National Cancer Institute on September 16, 1998. In this study, NOLVADEX ... ... Pay-Per-View - AAP General News - HighBeam Research

New standard in breast cancer treatment.  -  Apr 18, 2005
AstraZenecas Nolvadex (tamoxifen) has been the standard therapy for hormone-receptor positive breast cancer patients who have undergone surgery for the past ... $4.95 - M2 Presswire - ECNext

Reports: MLB Officials, Albany DA Met | Article from AP Online | …  -  Sep 11, 2007
On their own, Clomid and Nolvadex are not considered performance-enhancing drugs. A pharmacy based in Orlando, Fla., has been at the center of an ... Pay-Per-View - Associated Press/AP Online - HighBeam Research

AstraZeneca site extends breast cancer message.(Brief Article) |...  -  Nov 1, 2005
AstraZeneca markets the breast cancer medications Faslodex, Nolvadex and Arimidex in ... NOLVADEX DTC WINS FREDDIE An AstraZeneca unbranded breast cancer ... Pay-Per-View - Medical Marketing & Media - HighBeam Research

Article: "You see that ball as cancer. You see that ball, and you...  -  Mar 20, 2006
Article: ZENECA BEGINS ROLL-OUT OF ITS NOLVADEX BREAST ... ... Nolvadex, developed ... approved to decrease the incidence of breast cancer. ... Pay-Per-View - The Record - HighBeam Research

Article: Hoping to cast out breast cancer - The Record (Bergen...  -  Jan 2, 2006
Article: ZENECA BEGINS ROLL-OUT OF ITS NOLVADEX BREAST ... ... Nolvadex, developed ... approved to decrease the incidence of breast cancer. ... Pay-Per-View - The Record - HighBeam Research

Article: Display shows the hidden side of breast cancer - The Record...  -  Apr 28, 2006
Article: ZENECA BEGINS ROLL-OUT OF ITS NOLVADEX BREAST ... ... Nolvadex, developed ... approved to decrease the incidence of breast cancer. ... Pay-Per-View - The Record - HighBeam Research

Article: Looking for ways to help kids cope with cancer - The Record...  -  Nov 25, 2007
Article: ZENECA BEGINS ROLL-OUT OF ITS NOLVADEX BREAST CANCER DRUG ... ... Nolvadex, developed ... approved to decrease the incidence of breast cancer. ... Pay-Per-View - The Record - HighBeam Research

Baseball on HGH: 'We're doing everything we can'  -  Sep 13, 2007
In addition, officials from MLB and the players association are talking about adding more drugs to their banned substance list such as Clomid and Nolvadex, ... USA Today

A New Breast Cancer Option  -  Apr 19, 2006
The only drug currently approved for prevention is tamoxifen, sold under the brand name Nolvadex. It is mostly used to treat breast cancer, but when it is ... New York Times

Drugmakers Offer Aid To People 'on the Edge'  -  Jul 1, 2008
The drugmaker's first PAP, initiated in 1978, provided access to the breast cancer medicine Nolvadex. In the three decades since, the company has sponsored ... Washington Post

Cancer trial shows benefit of new drug  -  Dec 15, 2007
The study looked at the safety and effectiveness of tamoxifen, which is sold as Nolvadex, Istubal and Valodex, with the aromatase inhibitor anastrozole, ... Independent

Article: MEDICAL ANSWERS ON PREGNANCY AND CANCER.(News) - …  -  May 14, 2006
Article: ZENECA BEGINS ROLL-OUT OF ITS NOLVADEX BREAST CANCER DRUG ... ... Nolvadex, developed ... approved to decrease the incidence of breast cancer. ... Pay-Per-View - Post-Standard - HighBeam Research

Breast Cancer Hormone Therapy - Breast Cancer Health Information - NY...  -  Nov 10, 2008
Tamoxifen (Nolvadex) has been the standard hormonal drug used for breast cancer. It belongs to a class of compounds called selective estrogen receptor ... New York Times

Side effects force women off "safe" cancer pills  -  Sep 6, 2007
But the pill, sold by AstraZeneca under the brand name Nolvadex and also available generically, raises the risk of death from strokes and endometrial cancer ... Reuters UK

United States 2nd Circuit Court of Appeals Reports - IN RE TAMOXIFEN ...  -  Aug 10, 2006
1985, is sold by Zeneca (a former subsidiary of ICI which succeeded to the ownership rights of the tamoxifen patent) under the trade name Nolvadex®. ... Pay-Per-View - United States 2nd Circuit Court of... - Loislaw

United States 2nd Circuit Court of Appeals Reports - IN RE TAMOXIFEN ...  -  Nov 2, 2005
...rights of the tamoxifen patent) under the trade name Nolvadex®[fn6] Tamoxifen is the most widely prescribed drug for the treatment of breast cancer. ... Pay-Per-View - United States 2nd Circuit Court of... - Loislaw

Merck Loses Another Vioxx Case  -  Apr 21, 2006
Tamoxifen is sold as a generic and by AstraZeneca under the brand name Nolvadex., Raloxifene, brand name Evista, is manufactured by Eli Lilly & Co. ... NPR

Cáncer de mama en Ã?frica, el gran olvidado  -  Oct 3, 2007
El programa también incluyó el suministro de Nolvadex (tamoxifeno) para las pacientes. Una vez dotado el Centro de los equipos y el personal básico ... acceso.com

Brand Names/Synonyms:
Nolvadex is also known by the following brand names and/or synonyms,Citrate; Apo-Tamox; CCRIS 3275; CTX; Citofen; Crisafeno; Diemon; Gen-Tamoxifen; HSDB 6782; Istubol; Kessar; Noltam; Nolvadex; Nolvadex-D; Nourytam; Novo-Tamoxifen; Oncomox; Pms-Tamoxifen; Retaxim; TRANS FORM OF TAMOXIFEN; Tamizam; Tamofen; Tamone; Tamoxasta; Tamoxen; Tamoxifen; Tamoxifen Citrate; Tamoxifen Drug Standard Solution; Tamoxifen and Its Salts; Tamoxifene [Inn-French]; Tamoxifeno [Inn-Spanish]; Tamoxifenum [Inn-Latin]; Trans-Tamoxifen; Valodex; Zemide

Drug Category:
Nolvadex is categorized under the following by the FDA: Antineoplastic Agents; ATC:L02BA01

Dosage Forms:
TABLET

Absorption:
Not Available

Interactions:
[an error occurred while processing this directive]



Chemical IUPAC Name:
[5-(2-amino-6-oxo-3,9-dihydropurin-9-yl)-3,4-dihydroxy-tetrahydrofuran-2-yl]methoxy-[(3,4-dihydroxy-6-methyl-5-oxo-tetrahydropyran-2-yl)oxy-hydroxy-phosphoryl]oxy-phosphinicacid





Health Home | Conditions | Cancer | Medications | Surgery | Vaccines


The Cancer News Network


Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on cancernewsnetwork.org lead to other sites. cancernewsnetwork.org does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is CancerNewsNetwork.org responsible for dead or misdirected links.

IF YOU NEED A LINK OR TEXT REMOVED FROM THIS PAGE PLEASE CONTACT cancernewsnetwork (at) live.com.
We will do our best to accommodate your request.



COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy